Miller Aineinsider trades
In SEC Form 4 filings, Miller Aine is listed as SVP, DEV & HEAD OF IRE OFFICE of Theravance Biopharma, Inc. (TBPH). Miller Aine reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 24.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TBPHTheravance Biopharma, Inc. | SVP, DEV & HEAD OF IRE OFFICE | 4 | Sep 24 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 93,108 | not reported | not reported | 96,718 | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 96,718 | not reported | not reported | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D · derivative | 37,500 | $25.42 | $953,250 | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Aug 20 | Aug 24 | F | 6,258 | $16.95 | $106,073 | 189,826 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.